pioglitazone / Generic mfg. |
NCT00449553: Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone. |
|
|
| Completed | N/A | 326 | Europe, RoW | Pioglitazone and sulphonylurea, ACTOS®, AD4833, Pioglitazone and metformin | Takeda, Eli Lilly and Company | Diabetes Mellitus | 09/03 | 09/03 | | |
NCT01258322: Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients |
|
|
| Completed | N/A | 70 | RoW | Pioglitazone, pioglitazone (Actos®, Takeda®) 15mg | Huashan Hospital, Baxter Healthcare Corporation | Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia, Insulin Resistance, Inflammation | 09/08 | 09/08 | | |
|
| Completed | N/A | 246 | NA | Pioglitazone, Actos Tablets | Takeda | Type 2 Diabetes Mellitus | 06/11 | 06/11 | | |
NCT02678676: An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications |
|
|
| Completed | N/A | 3599 | Europe, RoW | No Intervention | Takeda | Diabetes Mellitus, Type 2 | 11/11 | 11/11 | | |
NCT02003014: Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment" |
|
|
| Completed | N/A | 899 | Japan | Pioglitazone, Actos | Takeda | Type 2 Diabetes Mellitus | 01/12 | 01/12 | | |
NCT01147627: Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients |
|
|
| Completed | N/A | 416 | RoW | exenatide injection, Byetta®(Eli Lilly and Company), Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R, Humalog Mix 25®(Eli Lilly and Company), Pioglitazone | Sun Yat-sen University, Eli Lilly and Company, Amylin Pharmaceuticals, LLC., Ministry of Health, China | Diabetes Mellitus, Type 2, Newly Diagnosed | 08/12 | 12/12 | | |
NCT02002975: Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus" |
|
|
| Completed | N/A | 18223 | NA | Pioglitazone, ACTOS | Takeda | Type 2 Diabetes Mellitus | 06/13 | 06/13 | | |
NCT02068508: Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment" |
|
|
| Completed | N/A | 1067 | NA | Pioglitazone, Actos | Takeda | Type 2 Diabetes Mellitus | 06/14 | 06/14 | | |
NCT02098746: Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone |
|
|
| Completed | N/A | 294 | Japan | Pioglitazone/glimepiride, Sonias combination tablets LD | Takeda | Type 2 Diabetes | 07/14 | 07/14 | | |
NCT01637935: Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes |
|
|
| Completed | N/A | 193099 | NA | Pioglitazone, Actos | Takeda, Kaiser Permanente, Department of Epidemiology at University of Pennsylvania | Diabetes, Bladder Cancer | 08/14 | 08/14 | | |
NCT02958956: Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus. |
|
|
| Completed | N/A | 236507 | NA | Pioglitazone | Takeda | Diabetes Mellitus, Type 2, Cancer | 05/15 | 05/15 | | |